NEW YORK (Reuters Health) – An implantable cardioverter-defibrillator (ICD) should be considered when patients with long QT syndrome (LQTS) have syncope while on beta-blockers. That’s according to authors…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses anticoagulation protocol for patients following mitral valve repair, and also the Maze procedure…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, Alzheimer’s Disease, which is currently a worldwide healthcare crisis and it is expected to…
NEW YORK (Reuters Health) – Researchers cut short a clinical trial of the endothelin blocker avosentan in patients with diabetic nephropathy because it was linked with fluid overload…
NEW YORK (Reuters Health) – Intravenous vitamin C before elective percutaneous coronary intervention (PCI) improves microcirculatory reperfusion, new research shows. This suggests oxidative stress is to blame for…
NEW YORK (Reuters Health) – Superficial venous thrombosis is often considered benign, but new research suggests that one in four patients also have deep venous thrombosis (DVT) or…
NEW YORK (Reuters Health) – A commercially available formula of Lactobacillus acidophilus and L. casei prevents Clostridium difficile infection and diarrhea during antibiotic treatment, according to a single-center…
NEW YORK (Reuters Health) – Patients hospitalized with community-acquired pneumonia are no better off when treated with prednisolone, according to trial results from The Netherlands. In fact, there’s…
NEW YORK (Reuters Health) – Oral anticoagulation might no longer be necessary after successful atrial fibrillation ablation, not even in patients at moderate-high risk for thromboembolism, a recent…
NEW YORK (Reuters Health) – In treating acute coronary syndromes, a slow response to clopidogrel in the first hour of administration predicts a low response at 24 hours…